Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Unlocking the potential: multimodal AI in biotechnology and digital medicine—economic impact and ethical challenges
4
Zitationen
2
Autoren
2025
Jahr
Abstract
Artificial Intelligence (AI) is revolutionizing biotechnology by accelerating advancements in drug discovery, genomics, medical imaging, and personalized medicine, thereby enhancing efficiency and reducing healthcare costs. This review emphasizes the transformative potential of multimodal AI-systems that integrate diverse data types such as genomic, clinical, and imaging data-to deliver more accurate and holistic biomedical insights. We explore AI's economic impact, role in driving innovation, and implications for both researchers and policymakers. Additionally, the review addresses key challenges, including data quality, algorithmic transparency, and ethical concerns, highlighting the urgent need for explainable AI models, robust regulatory frameworks, and equitable implementation to ensure responsible and impactful adoption across global healthcare systems.
Ähnliche Arbeiten
Explainable Artificial Intelligence (XAI): Concepts, taxonomies, opportunities and challenges toward responsible AI
2019 · 8.485 Zit.
Stop explaining black box machine learning models for high stakes decisions and use interpretable models instead
2019 · 8.371 Zit.
High-performance medicine: the convergence of human and artificial intelligence
2018 · 7.827 Zit.
Proceedings of the 19th International Joint Conference on Artificial Intelligence
2005 · 5.781 Zit.
Peeking Inside the Black-Box: A Survey on Explainable Artificial Intelligence (XAI)
2018 · 5.549 Zit.